Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Public ClinicalTrials.gov record NCT00623103. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 76-week Prospective, Open-label, Multicenter Study to Evaluate the Long-term Effect of Rivastigmine Capsule and Transdermal Patch on Worsening of the Underlying Motor Symptoms of PD in Patients With Mild to Moderately Severe Dementia Associated With Parkinson's Disease (PDD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to provide long-term safety data for rivastigmine capsule and transdermal patch treatments, in particular the effect of rivastigmine on worsening of the underlying motor symptoms of Parkinson's Disease (PD), in patients with mild to moderately severe dementia associated with PD.
Study identification
- NCT ID
- NCT00623103
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 583 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2008 (Type not available)
- Primary completion
- Nov 2010 (Actual)
- Completion
- Not listed
- Last update posted
- Nov 28, 2011
Started 2008
United States locations
- U.S. sites
- 17
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| 21st Century Neurology | Phoenix | Arizona | 85004 | — |
| Neurosearch, Inc. | Reseda | California | 91335 | — |
| Neurosearch II, Inc. | Ventura | California | 93003 | — |
| Sunrise Clinical Research, Inc. | Hollywood | Florida | 33021 | — |
| Collier Neurologic Specialists | Naples | Florida | 34102 | — |
| Comprehensive Neurology Specialists, PC | Suwanee | Georgia | 30024 | — |
| Neurological Associates | Meridian | Idaho | 83646 | — |
| Evanstan Northwestern Healthcare Medical Group | Glenview | Illinois | 60026 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Neurological Care of Central NY | Syracuse | New York | 13210-1853 | — |
| Neurology & Neuroscience Associates, Inc. | Akron | Ohio | 44302 | — |
| Square 1 Clinical Research | Erie | Pennsylvania | 16506 | — |
| Research Protocol Management Solutions | Pittsburgh | Pennsylvania | 15243 | — |
| Neurology Specialists of Dallas | Dallas | Texas | 75231 | — |
| Progressive Clinical Research | Bountiful | Utah | 84010 | — |
| Veterans Affairs Puget Sound Health Care System | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 110 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00623103, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 28, 2011 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00623103 live on ClinicalTrials.gov.